[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.150.215. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
August 6, 2003

Premature Termination of Clinical Trials

Author Affiliations
 

Letters Section Editor: Stephen J. Lurie, MD, PhD, Senior Editor.

JAMA. 2003;290(5):595. doi:10.1001/jama.290.5.595-a

To the Editor: Drs Psaty and Rennie1 discussed ethical imperatives against premature discontinuation of clinical trials for financial reasons. They argued that this causes harm by breaking the implicit and explicit agreements with research participants, investigators, and the oversight bodies that approved the protocol. Although the authors focused on industry-sponsored trials, their arguments actually apply to all clinical research regardless of sponsorship.

First Page Preview View Large
First page PDF preview
First page PDF preview
×